Back to search

Article

Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment

2024-06-17

Abstract excerpt

<h4>ABSTRACT</h4> Acral melanoma (AM) is an aggressive melanoma variant that arises from palmar, plantar, and nail unit melanocytes. Compared to non-acral cutaneous melanoma (CM), AM is biologically distinct, has an equal incidence across genetic ancestries, typically presents in advanced stage disease, is less responsive to therapy, and has an overall worse prognosis. Independent analysis of published genomic an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4117c792-f240-5d61-952e-6e45b6090eeb
DOI
10.1101/2024.06.15.599116
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironmentDOI 10.1101/2024.06.15.599116
Select a neighboring publication to make it the new centre.